The prostate health index (PHI) is a newer blood test that more accurately assesses your risk of prostate cancer than the ...

September is prostate cancer awareness month, so it’s a good time to remind men about the importance of prostate cancer ...

Prostate cancer cases have increased since 2014, with a 3% annual increase, likely due to changes in screening recommendations that may be resulting in more advanced and terminal cases of the disease.

Prostate cancer is the malignant growth of cells in the prostate, a walnut-sized gland below the bladder, that is responsible ...

THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

This comprehensive guide provides essential information to help patients and their families navigate their prostate cancer ...

Dr. Paul Gellhaus says PSA testing and modern biopsy methods ease fears and reassure patients, making early prostate cancer ...

For decades, it has been known that prostate specific antigen ‒ or PSA ‒ tests are a flawed way to diagnose prostate cancer. Many men have a high PSA without having cancer. Others have low PSA that ...

Medicare covers one annual prostate-specific antigen (PSA) test for people with prostates if they meet the eligibility guidelines and the test is medically necessary. Medicare typically covers one ...

Biochemical recurrence is when your PSA level starts to rise after finishing prostate cancer treatment, and it may sometimes indicate metastatic disease. Biochemical recurrence is a term for when your ...

The work was supported by the International Prostate Cancer Foundation, the Johns Hopkins Kimmel Cancer Center (NIH grant # ...